Who Attends?

Why Attend?
Most partnering conferences today are large and impersonal, where it can be a struggle to have meaningful confidential conversations without interruption or time pressures. The Biopharmaceutical Conference in Europe is successful because it is a small, by invitation only, conference where long lasting contacts are made and deals do get done!

Can you afford not to be part of this?

The Biopharmaceutical Conference in Europe invites biotech CEOs from Europe and the US to gather with senior executives from the major pharmaceutical and big biotech companies, to explore new business opportunities in a relaxed and informal setting away from day to day business distractions.

Attendance is limited to 150 invited participants to ensure that everyone gets maximum benefit from their attendance.

Everyone attending The Biopharmaceutical Conference in Europe is personally invited and invitations are extended to:

• CEOs, presidents or members of the board from biopharmaceutical companies focused on therapeutic drug development, delivery and/or marketing
• Senior Executives, such as Director or EVP, with responsibility for R&D, Licensing, M&A, Finance and Business Development from major pharmaceutical and biotechnology companies

Invitations are not extended to:

• Service and product providers to the biopharmaceutical industry such as CROs, data support or consultancy companies
• Banks, law firms, VC or funding companies
• Journalists and representatives from the media

The conference program does not allow for advertorial presentations, nor are there any companies exhibiting, you only need to enter into discussions with those executives with whom you really want to do business.

The conference is funded by private sponsorships and delegate registration fees and not exhibitor places. This formula has succeeded in retaining this event’s quality & reputation as one of the most exclusive in the Biotech conference calendar.